Ansell Limited

Ansell Limited

ANSLF
Ansell LimitedUS flagOther OTC
22.74
USD
- -
- -
3.22BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
9.36
11.15
10.75
10.39
9.32
10.36
11.08
12.38
15.79
15.4
13.1
12.58
13.79
Basic EPS, GAAP
0.96
0.29
1.22
1.05
1
3.37
0.83
1.22
1.92
1.25
1.17
0.59
0.7
Free Cash Flow per Basic Share
0.7
1.27
1.15
1.62
1.56
-0.32
-0.32
-0.5
-0.64
-0.57
-0.53
-0.49
-0.48
Dividend per Share
0.35
0.36
0.4
0.4
0.41
0.44
0.44
0.47
0.6
0.68
0.5
0.41
0.44
Book Value per Share
6.29
7.54
7.85
7.99
8.74
11.24
10.97
11.6
12.74
13.29
14.07
16.22
14.62
Tangible Book Value per Share
1.75
0.51
0.33
0.39
1.21
3.63
2.42
2.59
3.8
4
4.4
6.65
2.25
Basic Weighted Avg Shares
131
143
153
151
148
144
135
130
128
127
126
129
145
Sales/Revenue/Turnover
1,223
1,590
1,645
1,573
1,374
1,490
1,499
1,614
2,027
1,952
1,655
1,619
2,003
Operating Margin (%)
10.4
9.42
12.32
12.63
9.67
10.29
10.98
11.25
13.11
8.78
8.45
3.5
5.45
Depreciation Expense
25
35
35
38
45
40
38
38
64
65
68
73
75
Net Income, GAAP
125
42
188
159
148
484
112
159
247
159
148
76
102
Effective Tax Rate (%)
10.15
32.01
15.5
24.52
21.86
3.23
21.29
20.86
21.94
23.32
20.94
28.7
28.01
Profit Margin (%)
10.21
2.63
11.4
10.12
10.75
32.51
7.45
9.83
12.17
8.13
8.96
4.72
5.07
Working Capital
440
554
568
532
698
854
646
553
617
624
497
1,200
589
LT Debt
443
1,032
734
687
717
552
525
979
495
468
377
780
725
Total Equity
760
1,140
1,167
1,137
1,229
1,550
1,410
1,403
1,565
1,557
1,615
1,910
1,983
Return on Invested Capital (%)
9.63
5.76
8.27
7.95
5.43
7.24
6.35
6.49
9.08
6.31
5.29
1.65
2.81
Return on Capital (%)
10.76
3.22
10.15
9.09
8.41
24.02
6.02
7.53
10.99
7.89
7.18
3.45
4.38
Return on Common Equity (%)
15.06
4.4
16.47
13.2
11.82
33.33
7.21
10.6
15.68
9.56
8.56
3.96
4.82

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.9%
7.36%
3.8%
Free Cash Flow
-3.06%
2.31%
8.79%
Net Income, GAAP
16.83%
-0.48%
32.81%
Sales/Revenue/Turnover
2.79%
5.65%
23.71%
Total Cash Common Dividend
1.65%
2.83%
19.74%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,655
2024
- -
- -
- -
- -
1,619
2025
- -
- -
- -
- -
2,003

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.17
2024
- -
- -
- -
- -
0.59
2025
- -
- -
- -
- -
0.7

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.5
2024
- -
- -
- -
- -
0.41
2025
- -
- -
- -
- -
0.44

Company Description

APIChat
CEO
Nathalie Ahlstrom
Full Time Employees
15,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
678 Victoria Street Richmond VIC Australia 3121
IPO Date
Oct 15, 2010
Website
ansell.com
Business
Ansell Limited manufactures and markets personal protective equipment, including gloves and protective clothing, for healthcare professionals, industrial workers, and professional end-users worldwide. The company offers an extensive range of products such as chemical-resistant gloves, cleanroom gloves, cut-resistant gloves, disposable gloves, examination gloves, surgical gloves, radiation protection gloves, face masks, goggles, and chemical protective clothing; key brands include HyFlex, AlphaTec, BioClean, GAMMEX, MICROFLEX, AnsellGUARDIAN, Kimtech, and KleenGuard. Ansell operates in over 100 countries across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, with manufacturing facilities including sites in Malaysia, the United States, and India; it serves sectors including agriculture, automotive, chemical, energy, food processing, laboratory, life sciences, machinery, mining, and warehousing. Founded in 1905 and headquartered in Richmond, Victoria, Australia (ticker: ANSLF), the company traces its origins to the Ansell Rubber Company and has evolved through mergers, including its time as part of Pacific Dunlop, before refocusing on safety solutions. Recent developments include the completion of its US$640 million acquisition of Kimberly-Clark's Personal Protective Equipment business in July 2024, adding Kimtech, KleenGuard, and RightCycle brands to expand portfolio breadth in safety and scientific verticals; the launch of the HyFlex Precision Comfort Series with AEROFIT Technology for industrial applications; establishment of a new $80 million greenfield manufacturing plant in India; introduction of the Ansell Earth sustainability framework for eco-friendly PPE; and recognition as the 2025 Global Sustainable Hospital Supplies Company of the Year by Frost & Sullivan.

Company News

APIChat
  • Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction

  • Marissa Ansell on Active ETFs, Goldman Sachs Funds & More

  • Ansell Limited (ANSLY) Q2 2026 Earnings Call Transcript

  • Ansell Limited (ANSLY) Shareholder/Analyst Call Transcript

  • Ansell Limited (ANSLF) Q4 2025 Earnings Call Transcript

  • Ansell Limited (ANSLF) Q2 2025 Earnings Call Transcript

  • Australia Personal Protective Equipment Market Outlook Report 2024-2033 Featuring Medline Industries, Molnlycke Health Care, Ansell, and 3M

  • Ansell Limited (ANSLF) Q2 2024 Earnings Call Transcript

  • Ansell Limited (ANSLF) Q2 2023 Earnings Call Transcript

  • Ansell Limited (ANSLF) CEO Neil Salmon on Q4 2022 Results - Earnings Call Transcript

  • Ansell Limited (ANSLF) CEO Neil Salmon on Q2 2022 Results - Earnings Call Transcript

  • PPE Manufacturer Ansell Still Trading at a Nice Valuation